First-degree Ankle Sprains

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRehabilitation Centre Zivot

About this trial

Grade I ankle sprains are common, especially among athletes, women, teenagers, and physically active individuals. While over a million cases are reported annually, this represents only half of the total occurrences. These injuries can lead to complications like chronic ankle instability or osteoarthritis. Treatment often involves conservative methods, including the PRICEMMS protocol (protection, rest, ice, compression, elevation, modalities, medication, and support), while surgery is reserved for severe cases. Therapeutic exercises and rehabilitation play a key role in recovery. The Bowen technique, effective for other musculoskeletal issues, has not yet been extensively studied for Grade I ankle sprains.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Individuals diagnosed with Grade I acute ankle sprain confirmed by a specialist physician in radiology,

Age of participants ≥ 18 years,

Individuals of both sexes

Disqualifiers

Recurrent ankle injury,

Acute ankle sprains of Grade II and III,

Presence of other physical and/or mental health issues.

Trial population

The sample is a convenience sample and will include individuals diagnosed with Grade I acute ankle sprain who present for examination at the specified institutions. After a proper diagnosis, confirmation of inclusion in the study, and signed ethical consent for participation in the research, randomization of participants will be conducted using an electronic number generator on the website www.randomizer.org/form:htm.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Cryotherapy

    Other intervention

    cryotherapy, therapeutic exercises, the use of braces, and the Bowen technique.

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: Experimental Group1 intervention
Group B: Control Group1 intervention

Trial outcomes

Primary outcomes

1

Subjective assessment of pain intensity

Measured on a numerical scale ranging from 0 to 10

Time frame
3 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.